STAT+: Senate proposes expanding pharma penalties for hiking drug prices

WASHINGTON — A key Senate panel is expanding its plans to punish drug makers that hike prices faster than inflation, according to an internal Senate document described to STAT.

The policy, which is being considered as part of Democrats’ efforts to include drug pricing reforms in a sweeping government spending package, has the potential to change the way drug makers set launch prices for drugs, and how they choose to adjust prices over time.

Continue to STAT+ to read the full story…

Read Original Article: STAT+: Senate proposes expanding pharma penalties for hiking drug prices »